All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

TRT week one: separating real early effects from placebo

Benedict’s World

TikTok creator

1.7K viewsWatch on TikTok→

Quick answer

The creator is one week into injectable testosterone therapy via a regulated UK telehealth provider, having completed two subcutaneous injections on a biweekly schedule. He reports early subjective improvements in gym performance, energy regulation and reduced afternoon fatigue, which are plausible but cannot yet be attributed to stable pharmacological testosterone levels at this stage of treatment. He is also travelling internationally with his medication and a provider-issued travel letter, and is considering switching to intramuscular injection due to subcutaneous site discomfort.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @benbriscoe6 actually say?

After one week of injectable testosterone and two injections, this creator says his gym performance has already taken off. "My power, my recovery time, recovery time between reps, energy levels are off the scale," he says, claiming he has added more than 10kg across bench press, lateral pulldowns, and other lifts in a single week. He also reports his notorious afternoon energy crash has disappeared, replaced by what he calls "restless energy." He is self-injecting subcutaneously (under the skin) and is considering switching to intramuscular injections because of injection site stinging and discomfort.

He is appropriately cautious in places, acknowledging the possibility it could be placebo. He is also travelling with a provider-issued travel letter and his medication, which is genuinely good practice.

Does the science back this up?

The short answer is: partly, but not the way he thinks. Strength gains at one week are almost certainly not pharmacological. Testosterone enanthate and cypionate, the two most common injectable forms, have a half-life of roughly 4-5 days and 8 days respectively. Peak serum levels after a first injection typically take two to three weeks to stabilise.

The clinical literature is consistent on this. Bhasin et al. (2001, New England Journal of Medicine) showed dose-dependent increases in fat-free mass and muscle strength, but changes in maximal voluntary strength took six to twelve weeks to become statistically significant. A 2006 Cochrane review by Isidori et al. (European Journal of Endocrinology) similarly found meaningful strength changes in hypogonadal men appeared after approximately three months of treatment, not one week.

The energy and mood improvements are a different story. Some hypogonadal patients do report subjective wellbeing changes within days of a first injection, even before testosterone levels are fully stable. A 2000 study by Wang et al. (Journal of Clinical Endocrinology and Metabolism) noted early improvements in mood and energy in hypogonadal men, though these were also partly attributable to expectation effects.

What did they get wrong (or right)?

He got it right that the gains might be in his head, then he dismissed that possibility too quickly. A 10kg strength jump across multiple lifts in seven days is almost certainly not a testosterone effect at the tissue level. That is a placebo and psychological confidence effect, and those are real, documented and powerful, but he should not be attributing it to the drug itself at this stage.

He got the travel letter right. Travelling internationally with injectable testosterone and syringes without documentation is a serious legal risk in many countries. The fact his provider supplied one is standard practice and worth acknowledging.

His comment about "conversion from fat to muscle" is not how body composition actually works. Fat and muscle are different tissues. You do not convert one into the other. You can lose fat and gain muscle simultaneously under some conditions, but that is two separate processes, not a conversion.

His consideration of switching from subcutaneous to intramuscular injections is reasonable. IM injections typically produce higher peak concentrations and some users find them less irritating depending on the ester and carrier oil. His instinct to discuss it with his provider first is correct.

What should you actually know?

If you are considering TRT, here is what the evidence actually says. Testosterone therapy in genuinely hypogonadal men (low serum testosterone confirmed by at least two morning blood tests) does improve lean mass, strength, energy and sexual function over time. The key phrase is over time.

Meaningful muscle and strength changes typically take eight to twelve weeks minimum according to most clinical trials. Early subjective improvements in energy and mood are plausible and documented, but they are not a reliable signal that the drug is working pharmacologically yet. They may reflect placebo response, improved sleep, or early hormonal shifts that are hard to separate from expectation.

Injection site reactions including stinging and local soreness are common, particularly with higher-concentration testosterone formulations. The carrier oil (often sesame or cottonseed) and the concentration of the ester both affect this. These typically improve over time.

One thing worth flagging: he mentions a "fridge stored medication" separately from his room-temperature testosterone. If that is a co-medication like hCG (human chorionic gonadotropin, sometimes used alongside TRT to maintain testicular function), the cold chain requirements are different and worth checking carefully with his provider before travel.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For TRT week one: separating real early effects from placebo, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

TRT week one: separating real early effects from placebo should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

Use the health tools and supporting evidence to prepare questions for your clinician.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

The creator is one week into injectable testosterone therapy via a regulated UK telehealth provider, having completed two subcutaneous injections on a biweekly schedule.

FormBlends verdict

The creator is one week into injectable testosterone therapy via a regulated UK telehealth provider, having completed two subcutaneous injections on a biweekly schedule. He reports early subjective improvements in gym performance, energy regulation and reduced afternoon fatigue, which are plausible but cannot yet be attributed to stable pharmacological testosterone levels at this stage of treatment. He is also travelling internationally with his medication and a provider-issued travel letter, and is considering switching to intramuscular injection due to subcutaneous site discomfort.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is one week into injectable testosterone therapy via a regulated UK telehealth provider, having completed two subcutaneous injections on a biweekly schedule. He reports early subjective improvements in gym performance, energy regulation and reduced afternoon fatigue, which are plausible but cannot yet be attributed to stable pharmacological testosterone levels at this stage of treatment. He is also travelling internationally with his medication and a provider-issued travel letter, and is considering switching to intramuscular injection due to subcutaneous site discomfort.
  • Testosterone cypionate and enanthate have half-lives of 8 and 4-5 days respectively, meaning stable serum levels typically take 2-3 weeks to establish after starting treatment.
  • Bhasin et al. (2001, NEJM) found measurable strength increases in hypogonadal men on TRT occurred at 6-12 weeks, not within the first week.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Testosterone cypionate and enanthate have half-lives of 8 and 4-5 days respectively, meaning stable serum levels typically take 2-3 weeks to establish after starting treatment.
  • Bhasin et al. (2001, NEJM) found measurable strength increases in hypogonadal men on TRT occurred at 6-12 weeks, not within the first week.
  • Early subjective improvements in energy and mood are documented in hypogonadal patients starting testosterone, but are difficult to separate from expectation effects at one week.
  • Wang et al. (2000, JCEM) reported early wellbeing improvements in hypogonadal men on TRT, supporting the creator's energy claims as plausible, even if not definitively pharmacological yet.
  • Fat and muscle are different tissues with distinct metabolic pathways. Testosterone reduces fat mass and increases lean mass as two separate processes, not through conversion.
  • Travelling internationally with injectable testosterone and syringes without provider documentation carries real legal risk in many jurisdictions. A travel letter is correct practice.
  • Injection site stinging is common with oil-based testosterone esters, particularly at higher concentrations, and switching to IM administration is a legitimate clinical option to discuss with a prescriber.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Benedict’s World · TikTok creator

1.7K views on this video

TRT one week in! How’s it going! #trt #menofmanual #manual #gym #gymgains

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Not medical advice. This video was made by Benedict’s World, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.